These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 17653082)
1. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer. Ying H; Willingham MC; Cheng SY Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082 [TBL] [Abstract][Full Text] [Related]
2. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Kim CS; Ying H; Willingham MC; Cheng SY Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711 [TBL] [Abstract][Full Text] [Related]
3. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Kato Y; Ying H; Willingham MC; Cheng SY Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Furuya F; Lu C; Willingham MC; Cheng SY Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507 [TBL] [Abstract][Full Text] [Related]
5. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Guigon CJ; Zhao L; Willingham MC; Cheng SY Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818 [TBL] [Abstract][Full Text] [Related]
6. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice. Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579 [TBL] [Abstract][Full Text] [Related]
8. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer. Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101 [TBL] [Abstract][Full Text] [Related]
9. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Lu C; Zhao L; Ying H; Willingham MC; Cheng SY Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453 [TBL] [Abstract][Full Text] [Related]
10. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression. Ying H; Furuya F; Zhao L; Araki O; West BL; Hanover JA; Willingham MC; Cheng SY J Clin Invest; 2006 Nov; 116(11):2972-84. PubMed ID: 17039256 [TBL] [Abstract][Full Text] [Related]
11. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Suzuki H; Willingham MC; Cheng SY Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073 [TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone receptor-specific interactions with steroid receptor coactivator-1 in the pituitary. Sadow PM; Koo E; Chassande O; Gauthier K; Samarut J; Xu J; O'Malley BW; Seo H; Murata Y; Weiss RE Mol Endocrinol; 2003 May; 17(5):882-94. PubMed ID: 12576486 [TBL] [Abstract][Full Text] [Related]
13. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis. Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358 [TBL] [Abstract][Full Text] [Related]
14. Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Kamiya Y; Zhang XY; Ying H; Kato Y; Willingham MC; Xu J; O'Malley BW; Cheng SY Endocrinology; 2003 Sep; 144(9):4144-53. PubMed ID: 12933689 [TBL] [Abstract][Full Text] [Related]
15. Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Ying H; Furuya F; Willingham MC; Xu J; O'Malley BW; Cheng SY Mol Cell Biol; 2005 Sep; 25(17):7687-95. PubMed ID: 16107715 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Jeyakumar M; Tanen MR; Bagchi MK Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239 [TBL] [Abstract][Full Text] [Related]
17. PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway. Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY Oncogene; 2006 May; 25(19):2736-47. PubMed ID: 16314832 [TBL] [Abstract][Full Text] [Related]
18. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer. Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792 [TBL] [Abstract][Full Text] [Related]
20. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]